McCain and Baldwin to Trump: Hold pharma’s feet to the fire on drug prices

Frustrated by White House efforts to tackle rising drug prices, a pair of U.S. lawmakers is urging the Trump administration to more squarely focus on drug makers — by backing legislation requiring them to justify their pricing and provide a breakdown of expenses before raising prices on some medicines.

In a to be sent on Monday to President Trump, Sens. Tammy Baldwin (D-Wis.) and John McCain (R-Ariz.) urge him to “make good on your promise” last May. An identical bill was also introduced in the House, but both have languished.